(DDS) Dillard's - NYSE
Sector: Consumer Cyclical | Industry: Department Stores | Exchange: NYSE (USA) | Market Cap: 8.836m USD | Total Return: 45.5% in 12m
Avg Turnover: 68.4M
EPS Trend: -94.7%
Qual. Beats: 0
Rev. Trend: -91.5%
Qual. Beats: 1
Warnings
Earnings expected to drop: P/E 13.4 → Forward 31.2
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Dillards, Inc. (DDS) is a regional department store chain operating primarily across the Southeast, Southwest, and Midwest United States. The company maintains a diverse inventory including fashion apparel, accessories, cosmetics, and home furnishings through physical retail locations, clearance centers, and its e-commerce platform. Uniquely, the firm also operates an internal general contracting division responsible for the construction and remodeling of its physical storefronts.
The broadline retail sector relies heavily on inventory turnover and consumer discretionary spending patterns. Unlike many competitors that outsource real estate development, Dillards integrated construction model allows for greater control over capital expenditures related to store maintenance and expansion. Historical performance in this sector is often tied to the ability to balance brick-and-mortar overhead with growing digital sales channels.
For a detailed breakdown of the companys financial health, investors may find it useful to review the metrics on ValueRay. Founded in 1938 and headquartered in Little Rock, Arkansas, the company remains a significant player in the domestic retail landscape.
- High insider ownership and aggressive share buybacks drive earnings per share growth
- Consumer spending shifts in the Sun Belt region impact same-store sales
- Private label brand expansion improves gross margins versus third-party apparel
- Inventory management efficiency maintains profitability amid volatile retail demand cycles
- Real estate ownership reduces occupancy costs and provides significant asset backing
| Net Income: 657.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 2.39 > 1.0 |
| NWC/Revenue: 26.64% < 20% (prev 24.70%; Δ 1.94% < -1%) |
| CFO/TA 0.20 > 3% & CFO 845.0m > Net Income 657.4m |
| Net Debt (-828.3m) to EBITDA (986.8m): -0.84 < 3 |
| Current Ratio: 2.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.6m) vs 12m ago -1.27% < -2% |
| Gross Margin: 37.81% > 18% (prev 40.29%; Δ -2.49% > 0.5%) |
| Asset Turnover: 164.2% > 50% (prev 168.0%; Δ -3.81% > 0%) |
| Interest Coverage Ratio: 19.71 > 6 (EBIT TTM 808.6m / Interest Expense TTM 41.0m) |
| A: 0.43 (Total Current Assets 3.05b - Total Current Liabilities 1.29b) / Total Assets 4.14b |
| B: 1.59 (Retained Earnings 6.56b / Total Assets 4.14b) |
| C: 0.20 (EBIT TTM 808.6m / Avg Total Assets 4.02b) |
| D: 0.96 (Book Value of Equity 2.03b / Total Liabilities 2.11b) |
| Altman-Z'' = 10.31 = AAA |
| DSRI: 0.82 (Receivables 47.1m/56.9m, Revenue 6.61b/6.56b) |
| GMI: 1.07 (GM 40.29% / 37.81%) |
| AQI: 1.25 (AQ_t 0.04 / AQ_t-1 0.03) |
| SGI: 1.01 (Revenue 6.61b / 6.56b) |
| TATA: -0.05 (NI 657.4m - CFO 845.0m) / TA 4.14b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of June 20, 2026, the stock is trading at USD 554.86 with a total of 110,453 shares traded.
Over the past week, the price has changed by -9.67%,
over one month by +4.68%,
over three months by -4.93% and
over the past year by +45.51%.
Dillard's has received a consensus analysts rating of 2.00. Therefore, it is recommended to sell DDS.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 537 | -3.2% |
P/E Trailing = 13.4421
P/E Forward = 31.1526
P/S = 1.3377
P/B = 4.7032
P/EG = 2.2358
Revenue TTM = 6.61b USD
EBIT TTM = 808.6m USD
EBITDA TTM = 986.8m USD
Long Term Debt = 425.7m USD (from longTermDebt, last quarter)
Short Term Debt = 105.4m USD (from shortTermDebt, last quarter)
Debt = 589.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 33.7m
Net Debt = -828.3m USD (calculated: Debt 589.1m - CCE 1.42b)
Enterprise Value = 8.01b USD (8.84b + Debt 589.1m - CCE 1.42b)
Interest Coverage Ratio = 19.71 (Ebit TTM 808.6m / Interest Expense TTM 41.0m)
EV/FCF = 10.66x (Enterprise Value 8.01b / FCF TTM 751.3m)
FCF Yield = 9.38% (FCF TTM 751.3m / Enterprise Value 8.01b)
FCF Margin = 11.37% (FCF TTM 751.3m / Revenue TTM 6.61b)
Net Margin = 9.95% (Net Income TTM 657.4m / Revenue TTM 6.61b)
Gross Margin = 37.81% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 42.48% (prev 33.95%)
Tobins Q-Ratio = 1.94 (Enterprise Value 8.01b / Total Assets 4.14b)
Interest Expense / Debt = 6.97% (Interest Expense 41.0m / Debt 589.1m)
Taxrate = 18.74% (151.5m / 808.5m)
NOPAT = 657.1m (EBIT 808.6m * (1 - 18.74%))
Current Ratio = 2.37 (Total Current Assets 3.05b / Total Current Liabilities 1.29b)
Debt / Equity = 0.29 (Debt 589.1m / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = -0.84 (Net Debt -828.3m / EBITDA 986.8m)
Debt / FCF = -1.10 (Net Debt -828.3m / FCF TTM 751.3m)
Total Stockholder Equity = 1.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.34% (Net Income 657.4m / Total Assets 4.14b)
RoE = 33.85% (Net Income TTM 657.4m / Total Stockholder Equity 1.94b)
RoCE = 34.15% (EBIT 808.6m / Capital Employed (Equity 1.94b + L.T.Debt 425.7m))
RoIC = 25.03% (NOPAT 657.1m / Invested Capital 2.63b)
WACC = 9.46% (E(8.84b)/V(9.42b) * Re(9.71%) + D(589.1m)/V(9.42b) * Rd(6.97%) * (1-Tc(0.19)))
Discount Rate = 9.71% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.81 | Cagr: -1.66%
[DCF] Terminal Value 74.47% ; FCFF base≈697.2m ; Y1≈799.3m ; Y5≈1.18b
[DCF] Fair Price = 1.34k (EV 14.8b - Net Debt -828.3m = Equity 15.6b / Shares 11.6m; r=9.46% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -94.65 | EPS CAGR: -9.85% | SUE: 0.72 | # QB: 0
Revenue Correlation: -91.45 | Revenue CAGR: -2.10% | SUE: 1.00 | # QB: 1
EPS current Quarter (2026-07-31): EPS=4.21 | Chg30d=+0.96% | Revisions=+20% | Analysts=1
EPS next Quarter (2026-10-31): EPS=7.94 | Chg30d=+8.17% | Revisions=+20% | Analysts=1
EPS current Year (2027-01-31): EPS=33.84 | Chg30d=+5.59% | Revisions=+20% | GrowthEPS=-4.0% | GrowthRev=+0.8%
EPS next Year (2028-01-31): EPS=34.07 | Chg30d=+4.51% | Revisions=N/A | GrowthEPS=+0.7% | GrowthRev=+1.1%